In vitro and in situ studies have shown that, at the onset of MS, peripherally activated Th17 cells may reach the perivascular space and secrete IL-17 after recognition of cognate antigens presented by antigen presenting cells [19]. This evidence concerns the gene IL17A and myeloid sarcoma.